Received: 22 June 2020; Published on-line: 21 December 2020

Neuro-opthalmological and neuro-surgical aspects of papilledema

V. A. Vasyuta1, V. V. Biloshytsky1, L. D. Pichkur1, A. P. Huk1, O. Yu. Malysheva1, L. R. Borovyk2

1 Romodanov Neurosurgery Institute, National Academy of Medical Science of Ukraine; Kyiv (Ukraine)

2 Zaporizhzhia City Clinical Emergency Care Hospital; Zaporizhzhia (Ukraine)

E-mail: vasyuta.v@ukr.net 

TO CITE THIS ARTICLE: Vasyuta VA, Biloshytsky VV, Pichkur LD, Huk AP,  Malysheva OYu, Borovyk LR. Neuro-opthalmological and neuro-surgical aspects of papilledema. J.ophthalmol.(Ukraine).2020;6:55-60.  http://doi.org/10.31288/oftalmolzh202065560

Papilledema is optic disc swelling that is secondary to elevated intracranial pressure. Possible conditions causing high intracranial pressure and papilledema include brain neoplasms, head trauma, hydrocephalus, and other disorders of the central nervous system. Papilledema is diagnosed using ophthalmoscopy and/or neuroimaging. The differential diagnosis includes pseudopapilledema and inflammatory and vascular disorders of the optic disc. The treatment is aimed at reducing the intracranial pressure of the patient.

Keywords: papilledema, intracranial hypertension, optic disc



1.Nikiforov AS, Guseva MR. [Neuro-ophthalmology: a guide]. Moscow: GEOTAR – Media; 2008. Russian.

2.Hata M, Miyamoto K. Causes and prognosis of unilateral and bilateral optic disc swelling. Neuroophthalmology. 2017 Apr 10;41(4):187-191.  

Crossref   PubMed  

3.Trobe J. Papilledema: the vexing issues. J Neuroophthalmol. 2011 2011 Jun;31(2):175-86.

Crossref   PubMed 

4.Hayerh SS. Pathogenesis of optic disc edema in raised intracranial pressure. Prog Retin Eye Res. 2016 Jan;50:108-44.  

Crossref   PubMed  

5.Serova NK. [Clinical neuro-ophthalmology: Neurosurgical aspects]. Tver: Triada; 2011. Russian.

6.Merkulov II. [The optic nerve]. Erevan: Aiastan; 1979. Russian.

7.Rios–Montenegro EN, Anderson DR, David J. Intracranial pressure and ocular hemodynamics. Arch Ophthalmol. 1973 Jan;89(1):52-8. 

Crossref   PubMed 

8.Shahnovich A.R. [Intracranial hypertension and the concept of dynamic systemic organization of craniovertebral volumetric relations]. Proceedings of the 6th Moscow Neuro-ophthalmological Conference “Current Aspects of Neuro-ophthalmology”; Moscow; 2012; pp.37-38. Russian.

9.Eliseeva NM, Serova NK. [Papilledema and its differential diagnosis: A guide for physicians]. Moscow: Triadа; 2018. Russian. 

10.Serova NK. [Papilledema: A sign of intracranial hypertension]. In: Proceedings of the 6th Moscow Neuro-ophthalmological Conference “Current Aspects of Neuro-ophthalmology”; Moscow; 2012. Russian.

11.Friedman DI. Papilledema. In: Miller NR, Newman NJ, eds. Walsh and Hoyt’s Clinical Neurophthalmology. 6th ed. Philadelphia: Lippincott Williams & Wilkins; 2005. p. 237–91.

12.Eliseeva NM. [Clinical aspects of pathogenetic mechanisms of papilledema in neurosurgical brain disorders]. Dissertation for the degree of Dr Sc (Med). Moscow: Burdenko Neurosurgery Institute. 2009. Russian. 

13.Tron EG. [Visual pathway diseases]. Leningrad: Meditsina; 1968. Russian.

14.Huber A. Eye signs and symptoms in brain tumors. 3rd ed. St. Louis: Mosby; 1976.

15.Dermarkarian CR, Kini АT, Al Othman B, Lee AG. Neuro-Ophthalmic Manifestations of Intracranial Malignancies. J Neuroophthalmol. 2020 Sep;40(3):e31-e48.  

Crossref   PubMed 

16.Morozov VI, Iakovlev AA. [Visual pathway diseases: Clinical features, Diagnosis and Treatment]. Moscow: Binom; 2010. Russian.

17.Ibrahimova AA. [The state of the fundus as a predictive sign in patients with severe head trauma]. Neurokhirurgia i nevrologiia Kazakhstana. 2012;2,3 (27,27):80-83. Russian.

18.Mashima Y, Oshitari K, Imamura Y. High-resolution magnetic resonance imagining of the intraorbital optic nerve and subarachnoid space in patients with papilledema and optic atrophy. Arch Ophthalmology. 1996 Oct;114(10):1197-203.  

Crossref   PubMed  

19.Gustov AB, Sigrianskii KI, Stoliarova DP. [Practical neuro-ophthalmology] Vol.1. Nizhnii Novgorod: Nizhnenovgorodskii gosudarstvennyi universitet; 2000. Russian.

20.Samoilov AY. [Neuro-ophthalmological symptoms]. Moscow: Meditsina;1959. p.27-31. Russian. 

21.Micieli JA, Al-Obthani M, Sundaram AN. Pseudo-Foster Kennedy syndrome due to idiopathic intracranial hypertension. Can J Ophthalmol. 2014; 49:e99-e102.

Crossref   PubMed  

22.Friedman DI. Diagnostic criteria for idiopathic intracranial hypertension. Neurology. 2002 Nov 26; 59(10):1492-5. 

Crossref    PubMed  

23.Golenkov AK. [Retinal venous pulse]. Kaluga: Mikrokhirurgiia glaza;1992. Russian.

24.Corns R, Naveb L, Martin A. Transient obscuration of vision. BMJ Case Rep. 2012; bcr 2012006740.

Crossref   PubMed  

25.Obuchowska I, Mariak Z. The importance of visual field testing in patients with papilledema and idiopathic intracranial hypertension. Klinika Oczna. 2017; 119(1):13-5.

26.Wall M, Johnson CA, Cello KEm et al. Visual field outcomes for the idiopathic intracranial hypertension treatment trial (IIHTT). Invest Ophthalmol Vis Sci. 2016 Mar;57(3):805-12. 

Crossref   PubMed 

27.Tamburrelli C, Salgarello T, Caputo CG. Ultrasonographic evaluation of optic disc swelling: comparison with CSLO in idiopathic intracranial hypertension. Invest Ophthalmol Vis Sci. 2000 Sep;41(10):2960-6.

28.Karam EZ. Optical coherence tomography of the retinal nerve fibre layer in mild papilloedema and pseudopapilloedema. Br J Ophthalmol. 2005 Mar;89(3):294-8. 

Crossref   PubMed  

29.Fard MA, Sahraiyan A, Jalili J, Hejazi M. Optical Coherence Tomography Angiography in Papilledema Compared With Pseudopapilledema. Invest Ophthalmol Vis Sci. 2019 Jan 2;60(1):168-75. 

Crossref   PubMed  

30.Masoud AF, Alireza S, Jalil J. Optical Coherence tomography angiography in papilledema compared with pseudopapilledema. Invest Ophthalmol Vis Sci. 2019 Jan 2;60(1):168-175. 

Crossref   PubMed

31.Rykun VS. [Additional ultrasonografic criteria in the differential diagnosis of congestive and pseudocongestive optic disks]. Vestn Oftalmol. 2006 Jul-Aug;122(4):9-12.. Russian.

32.Saenz R, Cheng H, Prager TC, et al. Use of A-scan Ultrasound and Optical Coherence Tomography to Differentiate Papilledema From Pseudopapilledema. Optom Vis Sci. 2017 Dec;94(12):1081-1089.  

Crossref   PubMed  

33.Pineles SL, Arnold AC. Fluorescein angiographic identification of optic disc drusen with and without optic disc edema. J Neuroophthalmol. 2012 Mar;32(1):17-22.  

Crossref   PubMed  

34.Chang MY, Velez FG, Demer JL. Accuracy of Diagnostic Imaging Modalities for Classifying Pediatric Eyes as Papilledema Versus Pseudopapilledema. Ophthalmology. 2017 Dec; 124(12):1839-48.

Crossref   PubMed  

35.Lam BL, Morais CG, Pasol J. Drusen of the optic disc. Curr Neurol Neurosci Rep. 2008 Sep;8(5):404-8. 

Crossref   PubMed 

36.Mohammed R, Sumayya J, Almarzougi ML, Lee AG. Papilledema: epidemiology, etiology and clinical management. Eye brain. 2015 Aug 17;7:47-57. 

Crossref   PubMed 

37.Sabaner CM, Duman R, Cetinkaya E, Inan S. Optic Disc Drusen, important Detail in differential Diagnosis of Optic Disc Edema. Ophthalmology Research: An International Journal. 2016;6(1):1-5.

Crossref   PubMed 

38.Simonett JM, Winges KM. Vitreopapillary Traction Detected by Optical Coherence Tomography. JAMA Ophthalmol. 2018 May 10;136(5):e180727.  

Crossref   PubMed

39.Tarabishy AB, Alexandrou TJ, Traboulsi EI. Syndrome of myelinated retinal nerve fibers, myopia, and amblyopia: a review. Surv Ophthalmol.  Nov-Dec 2007;52(6):588-96.  

Crossref    PubMed 

40.Van Stavern GP. Optic disc edema. Semin Neurol. 2007 Jul;27(3):233-43. 

Crossref   PubMed

41.Patrocinio JA, Patrocinio LG, Junior FB, da Cunha AR. Endoscopic decompression of the optic nerve in pseudotumor cerebri. Auris Nasus Larynx. 2005 Jun;32(2):199-203.

Crossref   PubMed

The authors certify that they have no conflicts of interest in the subject matter or materials discussed in this manuscript.